Gelesis Holdings Inc
Change company Symbol lookup
Select an option...
GLS Gelesis Holdings Inc
T AT&T Inc
BFCXX BlackRock Liquidity FedFund Fund Capital
VTR Ventas Inc
LTC LTC Properties Inc
CNK Cinemark Holdings Inc
TITN Titan Machinery Inc
AHL-C Aspen Insurance Holdings Ltd
EVBN Evans Bancorp Inc
CTXS Citrix Systems Inc
Go

Company profile

Gelesis Holdings, Inc., formerly Capstar Special Purpose Acquisition Corp., is a commercial stage biotherapeutics company built for consumer engagement. The Company focuses on advancing superabsorbent hydrogel therapeutics for chronic gastrointestinal (GI) diseases including excess weight, type two diabetes, Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH), functional constipation (FC), and inflammatory bowel disease. Its product, Plenity, is an orally administered capsule. Plenity is available by prescription via a telehealth consultation with a physician trained in weight management support, with free, unlimited follow-up visits as needed. Consumers can visit myplenity.com for online consultations. Its other pipeline candidate includes GS200 for weight loss in prediabetes and type two diabetes. It is also developing GS300 for the treatment of NAFLD and NASH, and GS500 for the treatment of FC.

Closing Price
$4.90
Day's Change
-0.05 (-1.01%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.98
Day's Low
4.79
Volume
(Below Average)
Volume:
69,268

10-day average volume:
82,639
69,268
  • Prev Close
    4.95
  • Today's Open
    4.91
  • Day's Range
    4.79-4.98
  • Avg Vol (10-day)
    82.6K
  • Last (time)
    3:59p ET 05/18/22
  • Last (size)
    55
  • 52-Wk Range
    2.55 - 12.23
    LowHigh
  • (01/10/22 - 02/24/22)
    92.16%
  • 87.8%
  • Market Cap
    354.7M
  • Shares Outstanding
    72.4M
  • --
  • --x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • --
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.